Nimed (Nimesulide)

Nimesulide, the active ingredient in Nimed, is a nonsteroidal anti‑inflammatory drug presented as a topical formulation for cutaneous use. It is used to relieve mild to moderate pain and inflammation in conditions such as osteoarthritis and musculoskeletal disorders. GNH USA supplies Nimed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nimed, a COX‑2 selective NSAID, is employed in several inflammatory and pain‑related conditions. - Mild to moderate pain: provides analgesic relief in acute and chronic pain states. - Osteoarthritis: reduces joint inflammation and improves functional mobility. - Musculoskeletal pain: alleviates inflammation and discomfort associated with strains, sprains, and overuse injuries.

Adverse reactions may occur with Nimed use and are categorized by frequency and severity.

Common Side Effects: - Skin irritation at the application site. - Mild gastrointestinal discomfort. - Headache. - Dizziness. - Transient increase in liver enzymes.

Serious or Rare Side Effects: - Severe allergic reactions (e.g., Stevens‑Johnson syndrome). - Hepatotoxicity presenting as jaundice or elevated liver enzymes. - Renal impairment or failure. - Cardiovascular events such as hypertension or thrombotic episodes.

Before prescribing Nimed, clinicians should consider several safety aspects. - Hepatic function: assess baseline liver enzymes and monitor periodically. - Renal function: evaluate kidney status, especially in patients with pre‑existing impairment. - Cardiovascular risk: use cautiously in individuals with hypertension or a history of thrombotic disease. - Pregnancy and lactation: avoid use unless clearly indicated and benefits outweigh risks. - Concomitant NSAIDs: do not combine with other NSAIDs to reduce risk of adverse effects. - Store at below 25°C: keep in the original packaging, protect from moisture and direct light.

Nimed may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other COX‑2 inhibitors: additive toxicity. - Hepatotoxic drugs (e.g., certain antituberculars): heightened liver injury.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in antihypertensive effect. - ACE inhibitors or ARBs: may affect renal function. - Lithium: potential for increased lithium levels.